Cancer

National Jewish Health is leading the way in lung cancer research, focusing on early detection, novel treatments and individualized care. Researchers have identified proteins that slow tumor growth by preventing the formation of blood vessels necessary for their survival. Research includes the use of advanced imaging technologies and the development of immunotherapies that target specific cancer cells while sparing healthy tissue. By combining cutting-edge technologies with innovative therapeutic strategies, National Jewish Health aims to improve survival rates and quality of life for individuals diagnosed with lung cancer. Here is an overview of our cancer research programs:

• Lung Cancer Research: National Jewish Health is a leader in lung cancer research, exploring innovative ways to diagnose and treat the disease. Our work includes studying the genetic and molecular changes in lung cancer to develop targeted therapies and improve early detection methods.
• Immunotherapy Research: Researchers at National Jewish Health investigate how the immune system interacts with cancer cells. We aim to develop and refine immunotherapy approaches that harness the body's own immune system to fight cancer more effectively.
• Personalized Medicine: Our physician-scientists focus on tailoring cancer treatments to individual patients based on their unique genetic and molecular profiles. This personalized approach aims to enhance the effectiveness of treatments and minimize side effects.
• Clinical Trials and Studies: We conduct clinical trials to evaluate new interventions and treatments for lung cancer. This includes testing new medications, therapies and preventive measures.
• Cancer Research Advancements: Discovery of the protein cdk6 role in breast cancer
  Use of liquid biopsies to detect early stage lung cancer.